[144] Savers Value Village, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Savers Value Village, Inc. (SVV) reports a proposed sale of 2,300 common shares through Fidelity Brokerage Services with an aggregate market value of $29,900.50. The filing lists the total number of outstanding shares as 155,555,984 and an approximate sale date of 09/05/2025. The securities are shown as acquired on 09/05/2025 pursuant to an option granted on 06/12/2019, and payment is indicated as cash. The form also discloses multiple sales by Richard Medway over the prior three months totaling 120,119 shares for approximately $1,360,877.75. The filer attests no undisclosed material adverse information and the notice is submitted as a live filing.

Positive

• Clear compliance with Rule 144 disclosure requirements including broker, share counts, and aggregate value
• Disclosure of acquisition details (option grant date 06/12/2019) provides provenance for the securities
• Detailed prior sales history for the past three months enhances transparency

Negative

• Significant insider selling in the past three months (120,119 shares) which may concern some investors
• No 10b5-1 plan date provided in the remarks, so it is unclear whether sales were pre-planned

Insights

Financial Analyst

TL;DR: A routine Section 144 sale filing showing a small scheduled sale and substantial prior insider disposals over the past three months.

The Form 144 documents a proposed sale of 2,300 common shares valued at $29,900.50 against 155,555,984 shares outstanding, which is immaterial in size relative to the total share count. However, the disclosed prior insider transactions by Richard Medway total 120,119 shares and roughly $1.36 million in proceeds over the past three months, indicating meaningful insider liquidity during the period. From a market-impact perspective, the single proposed sale is small, but the recent concentrated selling activity may be relevant for investors monitoring insider selling trends. The filing provides acquisition provenance (option grant dated 06/12/2019) and indicates cash payment.

Corporate Governance Expert

TL;DR: Form 144 appears compliant and transparent but reflects notable insider disposition in recent months.

The notice includes required disclosures: broker name and address, exact share counts, aggregate value, acquisition date and nature (option grant), and a brokered sale date. The signer affirms no undisclosed material adverse information, satisfying the attestation element. The series of prior sales by the same individual is documented in detail, which supports regulatory compliance and provides transparency on insider behavior. There is no indication in the filing of any trading plan adoption date or other 10b5-1 instruction in the remarks section.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2300	29900.50	155555984	09/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/05/2025	Option Granted - 06/12/2019	Issuer			2300	09/05/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/03/2025	17619	187642.35
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/18/2025	1800	18950.94
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/22/2025	600	6306.00
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/23/2025	4228	44415.99
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	07/31/2025	2637	27641.56
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	08/01/2025	45735	505108.16
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	08/04/2025	15000	172200.00
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	08/29/2025	15000	179700.00
Richard Medway 11400 S.E. 6th Street Suite 125 Bellevue WA 98004	Common	09/02/2025	17500	218912.75

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does the Form 144 for SVV cover?

The filing covers 2,300 shares of common stock proposed for sale via Fidelity Brokerage Services.

What is the aggregate market value and proposed sale date for the shares?

Aggregate market value is listed as $29,900.50 with an approximate sale date of 09/05/2025.

How many shares does Savers Value Village report outstanding in the filing?

The Form 144 reports 155,555,984 shares outstanding.

Who sold shares in the prior three months and how many were sold?

Richard Medway sold a total of 120,119 shares in multiple transactions over the past three months.

What were the gross proceeds from the prior three months of sales?

The disclosed gross proceeds from those sales total approximately $1,360,877.75.

How were the 2,300 shares acquired according to the filing?

The securities are shown as acquired on 09/05/2025 from an option granted on 06/12/2019, with payment noted as cash.